HHG & Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BIT
BFA
HHG & Company's LLY Position: Q1 2016 in Review
HHG & Company reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2016, selling an estimated $37.5K and leaving 10,234 shares worth $737K. The position accounts for 0.2% of the portfolio, ranked #102.
HHG & Company first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.56M in Q1 2015. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.
- HHG & Company held 10,234 shares of Eli Lilly worth $737K as of Q1 2016.
- HHG & Company sold 495 Eli Lilly shares in Q1 2016, an estimated $37.5K.
- Eli Lilly made up 0.2% of HHG & Company's portfolio in Q1 2016, its #102 holding.
- HHG & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
- HHG & Company's Eli Lilly position peaked at $1.56M in Q1 2015.
- 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.
Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.